Apneon
Founded Year
2003Stage
Series B | AliveTotal Raised
$17.1MLast Raised
$12M | 17 yrs agoMissing: Apneon's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Apneon's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Apneon
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Apneon is included in 1 Expert Collection, including Sleep Health & Wellness.
Sleep Health & Wellness
802 items
These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.
Apneon Frequently Asked Questions (FAQ)
When was Apneon founded?
Apneon was founded in 2003.
Where is Apneon's headquarters?
Apneon's headquarters is located at 20813 Stevens Creek Boulevard, Cupertino.
What is Apneon's latest funding round?
Apneon's latest funding round is Series B.
How much did Apneon raise?
Apneon raised a total of $17.1M.
Who are the investors of Apneon?
Investors of Apneon include Split Rock Partners, Frazier Healthcare Partners, Cutlass Capital and Pequot Venture Capital.
Who are Apneon's competitors?
Competitors of Apneon include ALung Technologies, MedShape, iTind, Mobius Therapeutics, Autonomic Technologies, Cianna Medical, Inspire Medical Systems, TearScience, LinguaFlex, TRIA Beauty and 12 more.
Compare Apneon to Competitors
Linguaflex is a medical device company with a patent pending technology to treat obstructive sleep apnea. LinguaFlex's LTR is implanted and designed to be comfortable, therefore addressing the lack of compliance as an issue in the successful treatment of OSA.
Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).
Neuromonics is an Australian company that has developed an FDA approved device for treatment of tinnitus over a six month process with 2 hours of use per day.
Stealth mode medical device company developing devices for drug delivery. Monterey Devices submitted a patent on device for buffering anesthetics.
Vascure is a medical device company. The company is developing an therapeutic device for percutaneous treatment of arterial disease. Vascure's system will offer a one-stop solution for restoring blood flow to narrowed or occluded blood vessels in a range of clinical conditions, including heavily calcified lesions. Vascure will provide Intervantionalists with a safe and easy to use device, shortening procedure time, allowing percutaneous treatment in cases previously requiring radical surgical procedures and generating improved clinical outcomes.
Valor Medical is a San Diego-based medical device company that has developed liquid embrolic technology for the treatment of cerebral aneurysms.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.